|Grant Number:||5R01CA160695-02 Interpret this number|
|Primary Investigator:||Gilmore, Anna|
|Organization:||University Of Bath|
|Project Title:||Tobacco Companies, Global Governance and Public Health|
DESCRIPTION (provided by applicant): Tobacco use is one of the strongest cancer-causing agents, and cigarette smoking remains the leading cause of preventable deaths in the United States. Tobacco use is also the world's leading cause of preventable death, with global mortality projected to rise from 5.4 million in 2005 to 8.3 million in 2030. This challenge has stimulated a substantial and innovative public health response, both at state and federal level and increasingly internationally. Notwithstanding such progress, developments in the global political economy, including in trade and global governance, continue to generate challenges for public health. Agreements designed to promote trade, the practices of international finance organizations and broader trends in national and supranational governance can each conflict with public health priorities. This is evident in the arbitration claim recently brought to the World Trade Organization (WTO) by Indonesia against Section 907 of the Family Smoking Prevention and Tobacco Control Act. Such conflicts have the potential to undermine progress in tobacco control. Tobacco document research (TDR) to date has dramatically increased understanding of industry strategies to undermine specific tobacco control policies, largely at national level. Yet understanding remains limited of how tobacco companies advance their global interests through broader strategies of engagement with trade and governance agendas, including via influence over economic and foreign policy, national and supranational regulatory processes, international organizations, and through working with other industries. Analysis of such strategies is a precondition for fully understanding the nature and extent of tobacco industry influence and for promoting policy coherence between global health concerns and trade, foreign policy and development agendas. Furthermore, the US and many other countries that have implemented wide-ranging tobacco control programs still face considerable difficulties in controlling their tobacco epidemics. Research that addresses ongoing developments in tobacco industry structure and tactics is, therefore, increasingly required to inform more innovative policy developments that will be essential to effectively addressing tobacco use in the future. This proposed project aims to: 1. Contribute to the methodological development of document-based research, examine continuity and change in corporate strategy, and develop a taxonomy of tobacco industry strategies to shape policy. 2. Examine the implications of trade agreements for tobacco control and global health. 3. Analyze the health implications for tobacco control of industry efforts to introduce wide ranging regulatory reforms and to influence non-governmental organizations and examine broader engagement in global health initiatives.
Exposing and addressing tobacco industry conduct in low-income and middle-income countries.
Authors: Gilmore AB, Fooks G, Drope J, Bialous SA, Jackson RR
Source: Lancet, 2015 Mar 14;385(9972), p. 1029-43.
Quantifying the influence of the tobacco industry on EU governance: automated content analysis of the EU Tobacco Products Directive.
Authors: Costa H, Gilmore AB, Peeters S, McKee M, Stuckler D
Source: Tob Control, 2014 Nov;23(6), p. 473-8.
EPub date: 2014 Aug 13.
Support for a tobacco endgame strategy in 18 European countries.
Authors: Gallus S, Lugo A, Fernandez E, Gilmore AB, Leon ME, Clancy L, La Vecchia C
Source: Prev Med, 2014 Oct;67, p. 255-8.
EPub date: 2014 Aug 10.
E-cigarettes: threat or opportunity?
Authors: Gilmore AB, Hartwell G
Source: Eur J Public Health, 2014 Aug;24(4), p. 532-3.
Government support for alcohol industry: promoting exports, jeopardising global health?
Authors: Collin J, Johnson E, Officer H, Hill S
Source: BMJ, 2014 Jun 6;348, p. g3648.
EPub date: 2014 Jun 6.
Representation and misrepresentation of scientific evidence in contemporary tobacco regulation: a review of tobacco industry submissions to the UK Government consultation on standardised packaging.
Authors: Ulucanlar S, Fooks GJ, Hatchard JL, Gilmore AB
Source: PLoS Med, 2014 Mar;11(3), p. e1001629.
EPub date: 2014 Mar 25.
Tobacco industry manipulation of data on and press coverage of the illicit tobacco trade in the UK.
Authors: Rowell A, Evans-Reeves K, Gilmore AB
Source: Tob Control, 2014 May;23(e1), p. e35-43.
EPub date: 2014 Mar 10.
How does the tobacco industry attempt to influence marketing regulations? A systematic review.
Authors: Savell E, Gilmore AB, Fooks G
Source: PLoS One, 2014;9(2), p. e87389.
EPub date: 2014 Feb 5.
Roll-your-own cigarettes in Europe: use, weight and implications for fiscal policies.
Authors: Gallus S, Lugo A, Ghislandi S, La Vecchia C, Gilmore AB
Source: Eur J Cancer Prev, 2014 May;23(3), p. 186-92.
Understanding the emergence of the tobacco industry's use of the term tobacco harm reduction in order to inform public health policy.
Authors: Peeters S, Gilmore AB
Source: Tob Control, 2015 Mar;24(2), p. 182-9.
EPub date: 2014 Jan 22.
Scotland and the public health politics of independence.
Authors: Smith KE, Collin J
Source: BMJ, 2013 Dec 20;347, p. f7595.
EPub date: 2013 Dec 20.
Towards a greater understanding of the illicit tobacco trade in Europe: a review of the PMI funded 'Project Star' report.
Authors: Gilmore AB, Rowell A, Gallus S, Lugo A, Joossens L, Sims M
Source: Tob Control, 2014 May;23(e1), p. e51-61.
EPub date: 2013 Dec 11.
Corporate philanthropy, political influence, and health policy.
Authors: Fooks GJ, Gilmore AB
Source: PLoS One, 2013;8(11), p. e80864.
EPub date: 2013 Nov 27.
Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials.
Authors: Peeters S, Gilmore AB
Source: PLoS Med, 2013;10(9), p. e1001506.
EPub date: 2013 Sep 10.
The Limits of Corporate Social Responsibility: Techniques of Neutralization, Stakeholder Management and Political CSR.
Authors: Fooks G, Gilmore A, Collin J, Holden C, Lee K
Source: J Bus Ethics, 2013 Jan;112(2), p. 283-299.
The truth about cigarette price increases in Britain.
Authors: Gilmore AB, Reed H
Source: Tob Control, 2014 May;23(e1), p. e15-6.
EPub date: 2013 Aug 12.
Seeking out 'easy targets'? Tobacco companies, health inequalities and public policy.
Authors: Clifford D, Hill S, Collin J
Source: Tob Control, 2014 Nov;23(6), p. 479-83.
EPub date: 2013 Jul 5.
International trade law, plain packaging and tobacco industry political activity: the Trans-Pacific Partnership.
Authors: Fooks G, Gilmore AB
Source: Tob Control, 2014 Jan;23(1), p. e1.
EPub date: 2013 Jun 20.
Corporate involvement in public health policy is being obscured.
Authors: Collin J, Hill S
Source: BMJ, 2013 May 28;346, p. f3429.
EPub date: 2013 May 28.
The transnational tobacco companies' strategy to promote Codentify, their inadequate tracking and tracing standard.
Authors: Joossens L, Gilmore AB
Source: Tob Control, 2014 May;23(e1), p. e3-6.
EPub date: 2013 Mar 12.
Illicit trade, tobacco industry-funded studies and policy influence in the EU and UK.
Authors: Fooks GJ, Peeters S, Evans-Reeves K
Source: Tob Control, 2014 Jan;23(1), p. 81-3.
EPub date: 2013 Jan 15.
The case for Ofsmoke: the potential for price cap regulation of tobacco to raise £500 million per year in the UK.
Authors: Branston JR, Gilmore AB
Source: Tob Control, 2014 Jan;23(1), p. 45-50.
EPub date: 2013 Jan 14.
Illicit cigarettes and hand-rolled tobacco in 18 European countries: a cross-sectional survey.
Authors: Joossens L, Lugo A, La Vecchia C, Gilmore AB, Clancy L, Gallus S
Source: Tob Control, 2014 May;23(e1), p. e17-23.
EPub date: 2012 Dec 10.
The case against a smoker's license.
Authors: Collin J
Source: PLoS Med, 2012;9(11), p. e1001343.
EPub date: 2012 Nov 13.
The 'diverse, dynamic new world of global tobacco control'? An analysis of participation in the Conference of the Parties to the WHO Framework Convention on Tobacco Control.
Authors: Plotnikova E, Hill SE, Collin J
Source: Tob Control, 2014 Mar;23(2), p. 126-32.
EPub date: 2012 Nov 14.
What is known about tobacco industry efforts to influence tobacco tax? A systematic review of empirical studies.
Authors: Smith KE, Savell E, Gilmore AB
Source: Tob Control, 2013 Mar;22(2), p. 144-53.
EPub date: 2012 Aug 12.
"Trade policy, not morals or health policy": the US Trade Representative, tobacco companies and market liberalization in Thailand.
Authors: MacKenzie R, Collin J
Source: Glob Soc Policy, 2012 Aug;12(2), p. 149-172.
Global health governance and the commercial sector: a documentary analysis of tobacco company strategies to influence the WHO framework convention on tobacco control.
Authors: Weishaar H, Collin J, Smith K, Grüning T, Mandal S, Gilmore A
Source: PLoS Med, 2012;9(6), p. e1001249.
EPub date: 2012 Jun 26.
Tobacco industry manipulation of tobacco excise and tobacco advertising policies in the Czech Republic: an analysis of tobacco industry documents.
Authors: Shirane R, Smith K, Ross H, Silver KE, Williams S, Gilmore A
Source: PLoS Med, 2012;9(6), p. e1001248.
EPub date: 2012 Jun 26.
Knowledge of the health impacts of smoking and public attitudes towards tobacco control in the former Soviet Union.
Authors: Roberts B, Stickley A, Gilmore AB, Danishevski K, Kizilova K, Bryden A, Rotman D, Haerpfer C, McKee M
Source: Tob Control, 2013 Nov;22(6), p. e12.
EPub date: 2012 Jun 15.
Tobacco control, global health policy and development: towards policy coherence in global governance.
Authors: Collin J
Source: Tob Control, 2012 Mar;21(2), p. 274-80.
Understanding the vector in order to plan effective tobacco control policies: an analysis of contemporary tobacco industry materials.
Authors: Gilmore AB
Source: Tob Control, 2012 Mar;21(2), p. 119-26.
Global Fund needs to address conflict of interest.
Authors: Gilmore AB, Fooks G
Source: Bull World Health Organ, 2012 Jan 1;90(1), p. 71-2.
Uneasy money: the Instituto Carlos Slim de la Salud, tobacco philanthropy and conflict of interest in global health.
Authors: Burch T, Wander N, Collin J
Source: Tob Control, 2010 Dec;19(6), p. e1-9.